Altimmune, Inc. — insider transactions
3 transactions on record · CIK 1326190
Aggregates
computed from the filings belowPurchases, 12m
1
count of open-market buys
Sales, 12m
2
count of open-market sales
Buy / sell ratio, 12m
0.50
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$44.3K
Sold, 3m
$6.3K
Median disclosure lag
3.0 d
trade date to filing date
Largest single trade, 24m
$44.3K
2026-08-13
Director share, 12m
33.3%
of transactions where role is stated
Current run
1 buys
consecutive same-direction transactions
Net 3m flow
$37.9K
purchases minus sales
Total on record
3
Transactions
3 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | 2026-08-13 | 0 | Durso Jerome Benedict | Director, President and CEO | Open market purchase | 15,000 | $2.95 | $44.3K | filing |
| 2026-08-03 | 2026-07-31 | 3 | WEAVER GREGORY L | Chief Financial Officer | Grant or award | 1,753 | $2.41 | $4.2K | filing |
| 2026-08-03 | 2026-07-31 | 3 | Roberts M Scot | Chief Scientific Officer | Grant or award | 875 | $2.41 | $2.1K | filing |